Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Ultragenyx Pharmaceutical (0LIF.LSE) Q1 2024 Earnings
0LIF.LSE
15
Feb
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-2.33
-2.06
-1.79
-1.52
Details
Expected EPS
-1.7
Actual EPS
-1.52
Surprise EPS
0.18
Surprise Percent
+10.59%
Description
Ultragenyx Pharmaceutical (0LIF.LSE) has reported earnings of -1.52 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login